comparemela.com

Latest Breaking News On - Lifesci communications - Page 2 : comparemela.com

Syncromune, Inc. Announces FDA Clearance of IND Application

Syncromune, Inc. Announces FDA Clearance of IND Application
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United-states
Danielle-hobbs
Michael-tattory
Eamonn-hobbs
None-of-syncromune-inc
Drug-administration
Exchange-commission
Syncromune-inc
Corporate-communications
Lifesci-communications
Charles-link
Fort-lauderdale

Arrowhead Pharmaceuticals, Inc.: Arrowhead Pharmaceuticals Presents New Phase 2 Data of Zodasiran in Patients with Mixed Hyperlipidemia

Zodasiran significantly reduced triglycerides and atherogenic triglyceride rich lipoproteins across all dose levels at Week 24 Data presented at European Atherosclerosis Society 92nd Congress and

Vince-anzalone
Robert-rosenson
Brian-ritchie
Coll-cardiol
Kendy-guarinoni
Gugliucciaj-clin
Linkedin
Nasdaq
Lifesci-advisors
Arrowhead-pharmaceuticals-inc
European-atherosclerosis-society
Exchange-commission

Ashvattha Therapeutics to Present Preclinical Data at the CMSC and SNMMI Annual Meetings

Ashvattha Therapeutics to Present Preclinical Data at the CMSC and SNMMI Annual Meetings
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Toronto
Ontario
Canada
S-sakura-minami
Michael-fitzhugh
Renesmeec-kuo
Michelle-james-lab-at-stanford-university
Brain-imaging-council-young-investigator-award
Consortium-of-multiple-sclerosis-centers
Stanford-university
Metro-toronto-convention-center
Society-of-nuclear-medicine-molecular-imaging

Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting

Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Chicago
Illinois
United-states
Boston
Massachusetts
American
Heather-divecchia
Christopher-haqq
Craige-devoe
Elicio-therapeutics-inc
American-society-of-clinical-oncology
Rj-zuckerberg-cancer-center

Chiesi Global Rare Diseases Makes Debut in the Endocrinology Landscape with Multiple Presentations at the Endocrine Society's ENDO 2024 Meeting

Chiesi Global Rare Diseases Makes Debut in the Endocrinology Landscape with Multiple Presentations at the Endocrine Society's ENDO 2024 Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Phoenix
Arizona
United-states
China
University-of-arizona
Italy
Sweden
United-kingdom
Massachusetts
Boston
Canada
France
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.